In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease
- PMID: 20049706
- PMCID: PMC3378120
- DOI: 10.1002/emmm.200900020
In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease
Abstract
For many years research in Parkinson's disease (PD) has linked mitochondrial dysfunction with the characteristic loss of dopaminergic neurons of the substantia nigra, accumulation of cytoplasmic inclusions termed Lewy bodies, and motor dysfunction (Henchcliffe & Beal, 2008). The most compelling connection is that Parkinsonism can be observed in both humans and animals following exposure to inhibitors of complex I of the electron transport chain (Betarbet et al, 2002).
Comment on
-
Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function.EMBO Mol Med. 2009 May;1(2):99-111. doi: 10.1002/emmm.200900006. EMBO Mol Med. 2009. PMID: 20049710 Free PMC article.
References
-
- Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 2006;441:1162–1166. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases